Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.052 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |